Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors.
Journal: Investigational new drugs
Published: March 13, 2020
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.
Journal: Investigational new drugs
Published: June 13, 2013
Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 09, 2013
Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.
Journal: Journal of geriatric oncology
Published: November 21, 2012
Fluctuation of systemic immunity in melanoma and implications for timing of therapy.
Journal: Frontiers in bioscience (Elite edition)
Published: December 29, 2011
Showing 1-6 of 6
Last Updated: 09/26/2026